La Jolla Pharmaceutical Company Stock Price Up 15.6% Following Analyst Upgrade (LJPC)

Share on StockTwits

Shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) rose 15.6% during trading on Tuesday after Wedbush raised their price target on the stock from $32.00 to $33.00, Stock Ratings Network reports. The company traded as high as $12.08 and last traded at $11.87, with a volume of 442,601 shares traded. The stock had previously closed at $10.27.

A number of other analysts have also recently weighed in on LJPC. Analysts at Noble Financial raised their price target on shares of La Jolla Pharmaceutical Company from $16.00 to $34.00 in a research note on Tuesday, March 11th. They now have a “buy” rating on the stock. Separately, analysts at Chardan Capital raised their price target on shares of La Jolla Pharmaceutical Company to $54.00 in a research note on Tuesday, March 11th. They now have a “positive” rating on the stock. Finally, analysts at Chardan Capital initiated coverage on shares of La Jolla Pharmaceutical Company in a research note on Thursday, March 6th. They set a “buy” rating and a $32.00 price target on the stock.

The stock’s 50-day moving average is $10.68 and its 200-day moving average is $8.67. The company’s market cap is $50.739 billion.

La Jolla Pharmaceutical Company (NASDAQ:LJPC) last announced its earnings results on Monday, March 31st. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.17. Analysts expect that La Jolla Pharmaceutical Company will post $-1.20 EPS for the current fiscal year.

La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the development of therapeutic agents that inhibit the activity of galectins as a means of treating human diseases such as chronic organ failure and cancer.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Everest Re Group Sets New 52-Week High at $166.56
Everest Re Group Sets New 52-Week High at $166.56
SemGroup Corp Hits New 12-Month High at $88.83
SemGroup Corp Hits New 12-Month High at $88.83
RLJ Lodging Trust Reaches New 1-Year High at $30.21
RLJ Lodging Trust Reaches New 1-Year High at $30.21
Delek US Holdings Reaches New 1-Year High at $35.50
Delek US Holdings Reaches New 1-Year High at $35.50
Synchronoss Technologies Sets New 52-Week High at $45.16
Synchronoss Technologies Sets New 52-Week High at $45.16
Greenbrier Companies Hits New 52-Week High at $73.26
Greenbrier Companies Hits New 52-Week High at $73.26


Leave a Reply

 
© 2006-2014 Mideast Time.